AKR1B10 and hepatocellular carcinoma: Importantly, AKR1B10 exhibits a high degree of specificity in HCC, which provides a theoretical basis for the development of specific inhibitors targeting AKR1B10, which are expected to improve patients’ quality of life by producing only minor toxicities in the treatment of HCC (111).